Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review.

Date publication

janvier 2018

Journal

Journal of stomatology, oral and maxillofacial surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ZWETYENGA Narcisse

Tous les auteurs :
Compain H, Berquet A, Loison-Robert LS, Ahossi V, Zwetyenga N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29325766

Résumé

Rheumatoid arthritis (RA) is a frequent and co-morbid condition. One of the main complications is induced osteoporosis. Treatments related to this complication significantly modify oral and implant management. Affected patients represent a population at intermediate risk of osteonecrosis of the jaw (ONJ). The objective was to search the literature for durations of treatment with bisphosphonates at the time of ONJ occurrence in patients with RA in order to obtain an average duration.

Mots clés

Bisphosphonate, Implantology, Oral surgery, Osteonecrosis of the jaw, Rheumatoid arthritis

Référence

J Stomatol Oral Maxillofac Surg. 2018 Jan 8;: